Bit.bio
Synthetic Biology for Human Health Cells Reprogrammed bit.bio
WebBiology is our software, cells are our cures. Every cell type that we create has the potential to give rise to multiple next generation therapies. Precision reprogrammed human iPSC-derived cells for research and drug discovery. Using our opti-ox™ technology, we precisely, consistently and efficiently reprogram stem cells into any cell type at
Actived: Just Now
URL: https://www.bit.bio/
About us bit.bio
WebWhat we do. bit.bio is a synthetic biology company providing human cells for research, drug discovery and cell therapy. The company applies a patented safe harbour gene-targeting approach (opti-ox™; Pawlowski 2017) to inducibly express transcription factor combinations that reprogram human induced pluripotent stem cells (iPSCs) into highly defined and …
44th Annual TD Cowen Health Care Conference
WebThe conference will include a wide array of high-interest topical panels, including discussion of key medical devices, life science and diagnostic tools, therapeutics, health care delivery and the evolving political and regulatory landscape, all featuring TD Cowen's renowned medical, scientific, industry, legal and political consultants.
The "Brother Wright flight" of human health: Where can synbio …
WebIn this episode of the SynBioBeta Human Health podcast Fiona Mischel interviews bit.bio CEO Mark Kotter. They discuss how, with groundbreaking technologies like human cell reprogramming, we're now venturing beyond the "Brother Wright Flight" of early CAR-T therapies and making these novel cell therapies more accessible to all …
Product launch for our first disease model for studying Parkinson’s
WebThe PRKN (or PARK2) gene encodes the protein Parkin, which acts as a modulator of various inflammatory pathways and plays a critical role in maintaining mitochondrial health. Mutations in the Parkin gene are associated with the second most common genetic form of Parkinson's disease and are known to cause mitochondrial …
The next disruptive technology in medicine: human biology
WebThese devices will gather behavioural and biochemical data 24/7, constantly monitoring our health, and allow us to detect diseases very early by spotting changes in patterns in the collected data. As a consequence, the spectrum of diseases that we need to target will change. Early detection may improve the efficacy of current treatments.
iPSC-derived cells for research and drug discovery ioCells bit.bio
WebThe future of human health will be defined by technologies that accelerate the world's access to more effective medicines. Human cells are a cornerstone of fundamental disease research, drug discovery, and clinical translation. Yet, despite decades of research into iPSCs, emerging cures for some of the world’s most pervasive diseases have
Why did I start a healthcare and cultured meat company
WebOn Monday 26 April 2021, bit.bio CEO and founder Dr Mark Kotter published a blog on why he started a healthcare and cultured meat company. At first glance bit.bio – whose mission is ‘coding cells for health’ reprogramming them into any cell in the human body for use as cell therapies and research tools for drug discovery – and Meatable seem an unlikely …
bit.bio unveils cell therapy pipeline, lead candidate and expanded …
WebMost advanced therapeutic candidate (bbHEP01), encapsulated allogeneic txHepatocytes for the treatment of acute liver failure, expected to enter clinical development in 2025 and generate initial clinical data in 2026.Scientific Advisory Board (SAB) expanded to include three global experts in cell therapy with world-leading experience in drug …
Cultivated meat, cell therapies and opti-ox™ technology
WebToday Meatable, the cultivated meat company, announced their Series A fundraise of $47 million.. And there’s a connection to bit.bio. As well as being bit.bio’s CEO and founder, Dr Mark Kotter is also the co-founder of Meatable. The link – opti-ox™ technology which makes the manufacture of both bit.bio and Meatable products possible. “As a clinician, my focus …
Addressing current challenges of in vitro cell models
WebThe study of human health and disease using cell culture models has been ongoing for over 120 years, and yet issues such as accuracy and reproducibility of in vitro testing remain. In October 2021, an expert panel from across academia and industry convened at an Oxford Global Discovery UK conference to discuss these challenges as well as
42nd Annual J.P. Morgan Healthcare Conference
Web42nd Annual J.P. Morgan Healthcare Conference. The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community. In 2024, J.P. Morgan …
Bit Bio secures distribution agreement with Abcam
WebBit Bio announces agreement with Abcam, a global innovator in life science reagents and tools, to make Bit Bio’s iPSC derived functional human cells widely available to the global life science community. Over the course of the next two years this new partnership will provide an increasing range of highly defined, scalable and consistent human
BlueRock Therapeutics and bit.bio announce collaboration
WebCAMBRIDGE, Massachusetts, 07:30 EDT and Cambridge, UK 12:30 BST, 3 August 2023: BlueRock Therapeutics LP, a clinical stage cell therapy company and wholly-owned, independently operated subsidiary of Bayer AG, and bit.bio, the company coding human cells for novel cures, today announced a collaboration and option agreement for …
Challenging biology, Dr Mark Kotter, TEDxCambridgeUniversity
WebOn Saturday 20 March 2021, bit.bio CEO and founder Mark Kotter was a speaker at the TEDxCambridgeUniversity ‘Untangling networks’ event. Dr Kotter was speaking about his work as a neurosurgeon, stem cell biologist and an entrepreneur. Many of the conditions he faces as a doctor, whether they are cancers, genetic or degenerative conditions
Bank of America Healthcare Trailblazers Private Company …
WebBank of America Healthcare Trailblazers Private Company Conference. This event provides an opportunity for a select group of private companies across the Biotech, Digital Health, Med Tech, Tools & Diagnostics and Pharma Services sectors to build relationships with investors across the respective sectors. For the full list of companies attending
Jefferies Healthcare Conference
WebJefferies London Healthcare Conference is happening from 15th to the 17th November 2022, bringing together leading public and private companies from the pharmaceuticals, biotechnology, medical technology, and healthcare services sectors from the Americas, Europe, Middle East, Africa, Asia, and Australia. Co-founder and Chief Corporate Officer
Nobel Laureate Thomas Südhof and bit.bio CEO Mark Kotter to …
WebDr. Südhof, a world-renowned molecular and cellular neuroscientist and professor at Stanford University, will be joined by Dr. Kotter, a stem cell biologist, neurosurgeon at the University of Cambridge, and CEO of bit.bio, to discuss "Programming Human Cells: The Next Frontier of SynBio for Human Health." The fireside chat will …
How our culture enables scientists to bring in new technologies
WebWe brought the system in-house to further reduce turnaround time from the 5 weeks of the original system to under 1 week. This allows us to gain unprecedented clarity as to the genetic health of ourselves and demonstrates how our culture is open to scientists to make suggestions, innovate and implement improvements to the processes.
Top Categories
Popular Searched
› Southcoast health plan sign in
› Cms mental health regulations
› Genesis of mhs health records
› Penn state health and human development majors
› Spectrum behavioral health counseling
› Healthy cooking taste of home
› Importance of health care law
Recently Searched
› Uta health services appointment
› Southcoast health lab locations
› Pediatric mental health care access grants
› Healthywager weight loss challenge rules
› Health equity fellowship programs
› South bay mental health center gardena
› Cordant health solutions drug test
› Family health network chicago
› Construction health and safety procedures
› Furniture for healthcare facilities